نتائج البحث - Silvana Ancona

  • يعرض 1 - 1 نتائج من 1
تنقيح النتائج
  1. 1
    Adalimumab Biosimilars Demonstrate Long-Term Durability and Cost-Effectiveness in Paediatric Inflammatory Bowel Disease: A Real-World Two-Centre European Cohort Study

    Adalimumab Biosimilars Demonstrate Long-Term Durability and Cost-Effectiveness in Paediatric Inflammatory Bowel Disease: A Real-World Two-Centre European Cohort Study حسب Silvana Ancona, Katherine Armstrong, Chiara Longo, Rosalind Rabone, Victoria Merrick, Paul Henderson, Paolo Gandullia, David C. Wilson, Serena Arrigo, Richard K. Russell

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: